Masimo just won European clearance to introduce its Next Generation SedLine brain monitoring system for use on pediatric patients over one years old. The technology, already cleared in U.S. and Europe for adult patients, helps to assess brain function while the patient is under anesthesia. This can assist with maintaining the proper depths of anesthesia to prevent side effects, while helping to improve post-surgical recovery.
SedLine processes and analyzes signals from four electroencephalogram (EEG) leads positioned in a bilateral arrangement, outputting a number of parameters including Masimo’s own Patient State Index (PSi). The PSi within the SedLine has optimizations specific to pediatric patients that aims to provide consistent and accurate results.
Compared to the original SedLine, the Next Generation SedLine sports a PSi that is not as easily modulated by electromyography (EMG) interference and a Multitaper Density Spectral Array (DSA) that improves the fidelity of the EEG output.
“Next Generation SedLine is doing for brain function monitoring what Masimo SET® did for pulse oximetry,” said Joe Kiani, CEO of Masimo. “We believe Next Generation SedLine is the best and most advanced way to monitor depth of sedation, crucial to helping ensure patients with even the most challenging brains are appropriately anesthetized. We are gratified that its benefits are now available to those younger patients whose brains are particularly delicate and to whose wellbeing Masimo has always been so committed.”